No association between the tryptophan hydroxylase gene polymorphism and major depressive disorders and antidepressant response in a Korean population

Byung-Joo Ham, Min-Soo Lee, Heon-Jeong Lee, Rhee Hun Kang, Changsu Han, Myoung Jin Choi, Seung Hwan Lee, Seung Ho Ryu

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

The serotonergic neurotransmitter system has been implicated in major depressive disorder (MDD) and appears to be the target of a variety of antidepressants. Tryptophan hydroxylase (TPH) is the rate-limiting enzyme in serotonin biosynthesis, and selective serotonin re-uptake inhibitors exert their activity enhancing the general serotonergic tone. The goal of this study was to investigate whether the A218C polymorphism of the TPH gene is associated with MDD or antidepressant response. All patients were evaluated at the start and in the eighth week of using the 21-item Hamilton Depression Rating Scale. Genotyping was analyzed with polymerase chain reaction. There were no significant differences in genotypes and allele frequencies between the MDD patients (n=93) and the control group (n=127) and in the antidepressant response among TPH gene variants. Results suggest that the A218C polymorphism of the TPH gene does not play a major role in pathogenesis in MDD and does not serve as a modulator of antidepressant activity.

Original languageEnglish
Pages (from-to)299-301
Number of pages3
JournalPsychiatric Genetics
Volume15
Issue number4
DOIs
Publication statusPublished - 2005 Dec 1

Fingerprint

Tryptophan Hydroxylase
Major Depressive Disorder
Antidepressive Agents
Population
Genes
Serotonin Uptake Inhibitors
Gene Frequency
Neurotransmitter Agents
Serotonin
Genotype
Depression
Polymerase Chain Reaction
Control Groups
Enzymes

Keywords

  • Antidepressant response
  • Major depressive disorder
  • Polymorphism
  • Tryptophan hydroxylase

ASJC Scopus subject areas

  • Genetics(clinical)
  • Psychiatry and Mental health
  • Genetics
  • Neuroscience(all)

Cite this

No association between the tryptophan hydroxylase gene polymorphism and major depressive disorders and antidepressant response in a Korean population. / Ham, Byung-Joo; Lee, Min-Soo; Lee, Heon-Jeong; Kang, Rhee Hun; Han, Changsu; Choi, Myoung Jin; Lee, Seung Hwan; Ryu, Seung Ho.

In: Psychiatric Genetics, Vol. 15, No. 4, 01.12.2005, p. 299-301.

Research output: Contribution to journalArticle

@article{1638103b4764493a9fbdbe2e8a067c25,
title = "No association between the tryptophan hydroxylase gene polymorphism and major depressive disorders and antidepressant response in a Korean population",
abstract = "The serotonergic neurotransmitter system has been implicated in major depressive disorder (MDD) and appears to be the target of a variety of antidepressants. Tryptophan hydroxylase (TPH) is the rate-limiting enzyme in serotonin biosynthesis, and selective serotonin re-uptake inhibitors exert their activity enhancing the general serotonergic tone. The goal of this study was to investigate whether the A218C polymorphism of the TPH gene is associated with MDD or antidepressant response. All patients were evaluated at the start and in the eighth week of using the 21-item Hamilton Depression Rating Scale. Genotyping was analyzed with polymerase chain reaction. There were no significant differences in genotypes and allele frequencies between the MDD patients (n=93) and the control group (n=127) and in the antidepressant response among TPH gene variants. Results suggest that the A218C polymorphism of the TPH gene does not play a major role in pathogenesis in MDD and does not serve as a modulator of antidepressant activity.",
keywords = "Antidepressant response, Major depressive disorder, Polymorphism, Tryptophan hydroxylase",
author = "Byung-Joo Ham and Min-Soo Lee and Heon-Jeong Lee and Kang, {Rhee Hun} and Changsu Han and Choi, {Myoung Jin} and Lee, {Seung Hwan} and Ryu, {Seung Ho}",
year = "2005",
month = "12",
day = "1",
doi = "10.1097/00041444-200512000-00014",
language = "English",
volume = "15",
pages = "299--301",
journal = "Psychiatric Genetics",
issn = "0955-8829",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - No association between the tryptophan hydroxylase gene polymorphism and major depressive disorders and antidepressant response in a Korean population

AU - Ham, Byung-Joo

AU - Lee, Min-Soo

AU - Lee, Heon-Jeong

AU - Kang, Rhee Hun

AU - Han, Changsu

AU - Choi, Myoung Jin

AU - Lee, Seung Hwan

AU - Ryu, Seung Ho

PY - 2005/12/1

Y1 - 2005/12/1

N2 - The serotonergic neurotransmitter system has been implicated in major depressive disorder (MDD) and appears to be the target of a variety of antidepressants. Tryptophan hydroxylase (TPH) is the rate-limiting enzyme in serotonin biosynthesis, and selective serotonin re-uptake inhibitors exert their activity enhancing the general serotonergic tone. The goal of this study was to investigate whether the A218C polymorphism of the TPH gene is associated with MDD or antidepressant response. All patients were evaluated at the start and in the eighth week of using the 21-item Hamilton Depression Rating Scale. Genotyping was analyzed with polymerase chain reaction. There were no significant differences in genotypes and allele frequencies between the MDD patients (n=93) and the control group (n=127) and in the antidepressant response among TPH gene variants. Results suggest that the A218C polymorphism of the TPH gene does not play a major role in pathogenesis in MDD and does not serve as a modulator of antidepressant activity.

AB - The serotonergic neurotransmitter system has been implicated in major depressive disorder (MDD) and appears to be the target of a variety of antidepressants. Tryptophan hydroxylase (TPH) is the rate-limiting enzyme in serotonin biosynthesis, and selective serotonin re-uptake inhibitors exert their activity enhancing the general serotonergic tone. The goal of this study was to investigate whether the A218C polymorphism of the TPH gene is associated with MDD or antidepressant response. All patients were evaluated at the start and in the eighth week of using the 21-item Hamilton Depression Rating Scale. Genotyping was analyzed with polymerase chain reaction. There were no significant differences in genotypes and allele frequencies between the MDD patients (n=93) and the control group (n=127) and in the antidepressant response among TPH gene variants. Results suggest that the A218C polymorphism of the TPH gene does not play a major role in pathogenesis in MDD and does not serve as a modulator of antidepressant activity.

KW - Antidepressant response

KW - Major depressive disorder

KW - Polymorphism

KW - Tryptophan hydroxylase

UR - http://www.scopus.com/inward/record.url?scp=33645744529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645744529&partnerID=8YFLogxK

U2 - 10.1097/00041444-200512000-00014

DO - 10.1097/00041444-200512000-00014

M3 - Article

VL - 15

SP - 299

EP - 301

JO - Psychiatric Genetics

JF - Psychiatric Genetics

SN - 0955-8829

IS - 4

ER -